It’s looking less and less likely we’ll get a vaccine by the election
Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and
We’ve made it to Wednesday! How’s everyone holding up?Advertisement
Some news out of Sweden: Emmanuelle Charpentier and Jennifer Doudna have won the Nobel Prize in chemistry for their work in developing the gene-editing technology CRISPR! As a young science reporter, CRISPR was one of the first new(er) discoveries that I got thoroughly obsessed with. Last year, Erin Brodwin had a good conversation with Doudna that I’ll be revisiting today.
And in presidential updates, President Donald Trump’s doctor said Tuesday that Trump reported “no symptoms” from his
Elsewhere in healthcare news: It’s looking unlikely we’ll have an approved vaccine before the election, Clover Health’s ambitious growth plans rely on a new program, and the story of how Buoy Health got its first investors despite its founder’s home burning down weeks earlier.
Trump’s coronavirus vaccine czar is backing the FDA on safety standards that make a vaccine approval unlikely if not impossible before the election
Clover Health laid out ambitious growth plans as part of its $3.7 billion deal, but they rely on an untested new Medicare experiment
How the 33-year-old founder of Buoy Health raised his first investment wearing a T-shirt and jeans after his home burned down
- Dr. Andrew Le lost his home in a fire shortly before he pitched his company,
Buoy Health, to investors.
- “I literally didn’t have a place to live,” Lee said. At the time, he was couch-surfing.
- Now, his health information company helps more than 9 million people, and he figured out how to get health insurers and employers to pay for it.
- Business Insider named Le one of its “30 under 40” leaders transforming healthcare.
Read the full story from Kimberly Leonard here>>Advertisement
More stories we’re reading:
– Lydia Advertisement